# Central Puerto S.A.: financial statements, quarterly

CEPU · NYSE · CIK 1717161 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cepu.md) · [Financials](/companies/cepu/financials.md) · [Filings](/companies/cepu/filings.md) · [Insiders](/companies/cepu/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cepu/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2014-12-31) | period not labelled (2015-12-31) | period not labelled (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.2](/filings/0001654954-18-005797.md) | [0.7](/filings/0001654954-19-004986.md) | [0.1](/filings/0001654954-20-004595.md) | [0.3](/filings/0001654954-21-004609.md) | [0.7](/filings/0001654954-22-005521.md) | [3.1](/filings/0001654954-22-005521.md) | [0.4](/filings/0001654954-22-005521.md) | [0.5](/filings/0001654954-23-005229.md) | [28.8](/filings/0001654954-24-005154.md) | [29.3](/filings/0001292814-25-001645.md) | [3.8](/filings/0001292814-25-001645.md) |
| Current assets | $bn | not reported | not reported | [4.3](/filings/0001654954-18-005797.md) | [9.1](/filings/0001654954-19-004986.md) | [20.8](/filings/0001654954-20-004595.md) | [36.1](/filings/0001654954-21-004609.md) | [52.5](/filings/0001654954-22-005521.md) | [90.9](/filings/0001654954-23-005229.md) | [327](/filings/0001654954-24-005154.md) | [637](/filings/0001292814-25-001645.md) | [554](/filings/0001292814-25-001645.md) |
| Total assets | $bn | not reported | not reported | [12.7](/filings/0001654954-18-005797.md) | [34.3](/filings/0001654954-19-004986.md) | [88.1](/filings/0001654954-20-004595.md) | [162](/filings/0001654954-21-004609.md) | [239](/filings/0001654954-22-005521.md) | [391](/filings/0001654954-23-005229.md) | [1,189](/filings/0001654954-24-005154.md) | [3,056](/filings/0001292814-25-001645.md) | [2,662](/filings/0001292814-25-001645.md) |
| Current liabilities | $bn | not reported | not reported | [4.3](/filings/0001654954-18-005797.md) | [8.9](/filings/0001654954-19-004986.md) | [17.3](/filings/0001654954-20-004595.md) | [24.6](/filings/0001654954-21-004609.md) | [42.9](/filings/0001654954-22-005521.md) | [33.1](/filings/0001654954-23-005229.md) | [132](/filings/0001654954-24-005154.md) | [322](/filings/0001292814-25-001645.md) | [375](/filings/0001292814-25-001645.md) |
| Total liabilities | $bn | not reported | not reported | [7.6](/filings/0001654954-18-005797.md) | [17.3](/filings/0001654954-19-004986.md) | [37.4](/filings/0001654954-20-004595.md) | [81.2](/filings/0001654954-21-004609.md) | [112](/filings/0001654954-22-005521.md) | [144](/filings/0001654954-23-005229.md) | [376](/filings/0001654954-24-005154.md) | [1,191](/filings/0001292814-25-001645.md) | [799](/filings/0001292814-25-001645.md) |
| Shareholders' equity | $bn | [3.4](/filings/0001654954-18-005797.md) | [14.5](/filings/0001654954-19-004986.md) | [5.1](/filings/0001654954-18-005797.md) | [16.6](/filings/0001654954-19-004986.md) | [49.9](/filings/0001654954-20-004595.md) | [79.5](/filings/0001654954-21-004609.md) | [127](/filings/0001654954-22-005521.md) | [247](/filings/0001654954-23-005229.md) | [813](/filings/0001654954-24-005154.md) | [1,818](/filings/0001292814-25-001645.md) | [1,800](/filings/0001292814-25-001645.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 1,513,770,222 at 2025-12-31, from the cover of the [20-F filed 2026-04-22](/filings/0001292814-26-002446.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.